Arkansas and Massachusetts are the latest states to hold PBMs accountable, help preserve patient access to the medications right for them.
In 2024 alone, 24 states enacted 33 bills, leading to adoption of 74 policy changes that align with NACDS’ PBM reform and reimbursement priorities; more than 131 new state PBM reform laws were enacted from 2021-2023.
The move by HHS will help maintain continuity of patients’ access to pharmacies as states continue to achieve strong progress in enhancing their policies
New York State Department of Financial Services adopts new market conduct regulations that will enable the regulatory oversight, transparency and accountability of PBMs operating in the state
California patients and providers urge Gov. Newsom to sign SB 966, PBM reform legislation
California Senate Bill 966 would help rein in the harmful tactics of the PBM middlemen by providing much-needed oversight and transparency.
NACDS is asking Gov. Gavin Newsom to sign PBM reform in his state - and to fuel momentum across the nation.
HB 1993 includes important PBM reforms and protections for Pennsylvania families’ access to pharmacies for important services.
“Now is the time for Massachusetts to stop pharmaceutical benefit manipulation from inflating Bay Staters’ prescription drug prices and from jeopardizing access to trusted pharmacies and needed medications”
“Confronting the PBMs’ self-enriching tactics requires state and federal legislators and policymakers to do their part”
HB 579 will improve critical community access to care by enabling pharmacists to dispense HIV pre-exposure (PrEP) and post-exposure prophylaxis (PEP); becomes effective on August 1, 2024
“Confronting the PBMs’ self-enriching tactics requires state and federal legislators and policymakers to do their part.”
